Unknown

Dataset Information

0

Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.


ABSTRACT:

Background

Leptomeningeal metastases (LM), associated with poor prognosis, are frequent complications of advanced non-small cell lung cancer (NSCLC) patients, especially in patients with epidermal growth factor receptor (EGFR) mutations. Due to limited access to leptomeningeal lesions, the mutational landscape of LM has not been comprehensively investigated in large cohorts and the underlining biology of LM remains elusive. Some studies have explored the potential of cerebrospinal fluid (CSF) in reflecting the molecular profile of LM but with limited number of patients enrolled.

Methods

In this study, we performed capture-based targeted sequencing using a panel consisting of 168 lung cancer-related genes on matched CSF and plasma samples from 72 advanced NSCLC patients with confirmed LM to interrogate the potential of CSF as a source of liquid biopsy.

Results

We revealed a rate of detection of 81.5% and 62.5% for CSF and plasma, respectively (p = 0.008). The maximum allelic fraction (MaxAF) was also significantly higher in CSF (43.6% vs. 4.6%) (p < 0.001). CSF, harboring a unique genomic profile by having a significant number of CSF-specific mutations, primarily copy number variations, is superior to plasma in reflecting the mutational profile of LM. Further pathway enrichment analysis revealed that most of CSF-specific mutations participated in pathways relevant to the tumorigenesis and the development of metastases. Moreover, our data also revealed that TP53 loss of heterozygosity (LOH) predominantly existed in CSF (p < 0.001).

Conclusions

Collectively, we demonstrated that CSF provides a more comprehensive profile of LM than plasma in a large cohort, thus can be used as an alternative source of liquid biopsy for LM patients.

SUBMITTER: Ying S 

PROVIDER: S-EPMC6422486 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.

Ying Shenpeng S   Ke Honggang H   Ding Yan Y   Liu Yanmei Y   Tang Xiaowan X   Yang Dongyong D   Li Min M   Liu Junjun J   Yu Bing B   Xiang Jianxing J   Mao Xinru X   Han-Zhang Han H   Hu Wei W   Chen Lili L  

Cancer biology & therapy 20181105 4


<h4>Background</h4>Leptomeningeal metastases (LM), associated with poor prognosis, are frequent complications of advanced non-small cell lung cancer (NSCLC) patients, especially in patients with epidermal growth factor receptor (EGFR) mutations. Due to limited access to leptomeningeal lesions, the mutational landscape of LM has not been comprehensively investigated in large cohorts and the underlining biology of LM remains elusive. Some studies have explored the potential of cerebrospinal fluid  ...[more]

Similar Datasets

| S-EPMC8353541 | biostudies-literature
| S-EPMC9097599 | biostudies-literature
| S-EPMC8778711 | biostudies-literature
| S-EPMC5731867 | biostudies-other
| S-EPMC8708677 | biostudies-literature
| S-EPMC5570249 | biostudies-literature
| S-EPMC9178395 | biostudies-literature
2020-02-25 | GSE125193 | GEO
| S-EPMC7438284 | biostudies-literature